Correction of an inborn error of metabolism by intraportal hepatocyte transplantation in a dog model.

The aims of this study were (1) to assess portal hemodynamics during intraportal hepatocyte transplantation (HTX) in dogs, (2) to evaluate a new method for the detection of transplanted hepatocytes using 5-bromo-2'-deoxyuridine (BrdU) incorporation, and (3) to determine the metabolic effects of HTX on an inborn error of the purine metabolism in dalmatian dogs. HTX was performed by intraportal infusion of freshly isolated allogeneic beagle hepatocytes. Portal flow and pressure were monitored continuously during HTX. For the detection experiments, beagles received hepatocytes that had been exposed to BrdU during regeneration of the donor liver, induced by partial hepatectomy. For metabolic studies, dalmatian dogs were used as recipients. Repetitive HTX was performed. As judged by the portal hemodynamics, the number of hepatocytes that could be infused safely varied from 5 x 1O(8) to 8 x 1O(8) in beagles, to 1 x 10(9) in dalmatians. Transaminase levels showed a 5- to 6-fold increase (P=0.05) after HTX, but normalized within 3 weeks. BrdU-positive cells were identified in the recipient livers 2 weeks after HTX and 5-10% of the total amount of transplanted hepatocytes was retrieved. A significant (P=0.05) decrease in serum uric acid was demonstrated after repeated HTX in dalmatians. In conclusion, (1) intraportal HTX is feasible, but portal hypertension limits the maximum amount of hepatocytes that can be infused in one HTX; (2) BrdU labeling is an attractive method for the detection of transplanted hepatocytes in the recipient liver; and (3) after two consecutive hepatocyte transplantations, a temporary correction of the purine metabolism was accomplished in the dalmatian dog.

[1]  G. Zajicek.  Do livers "stream"? , 1995, The American journal of pathology.

[2]  J. Vacanti,et al.  Hepatocyte transplantation in biodegradable polymer scaffolds using the Dalmatian dog model of hyperuricosuria. , 1995, Transplantation proceedings.

[3]  G. Kazemier,et al.  Proliferative response of hepatocytes transplanted into spleen or solid support. , 1994, The Journal of surgical research.

[4]  James M. Wilson,et al.  Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia , 1994, Nature Genetics.

[5]  A. Fabrega,et al.  Transplantation of Hepatocytes: An In-Vitro and In-Vivo Study in Canines , 1994, Cell transplantation.

[6]  R. Palmiter,et al.  Replacement of diseased mouse liver by hepatic cell transplantation. , 1994, Science.

[7]  M. Kay,et al.  In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. , 1993, Science.

[8]  J. Wilson,et al.  Cell Transplantation in Liver-Directed Gene Therapy , 1993, Cell transplantation.

[9]  Tetsu Yamamoto,et al.  Beneficial Effect of Hepatic Stimulatory Substances on the Survival of Intrasplenically Transplanted Hepatocytes , 1993, Cell transplantation.

[10]  O. Terpstra,et al.  Successful prolonged correction of an inborn metabolic defect by heterotopic auxiliary liver transplantation in a dog model. , 1993, Transplantation proceedings.

[11]  P. Jansen,et al.  EVIDENCE OF METABOLIC ACTIVITY OF ADULT AND FETAL RAT HEPATOCYTES TRANSPLANTED INTO SOLID SUPPORTS , 1992, Transplantation.

[12]  J. Wilson,et al.  Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. , 1991, Science.

[13]  G. Zajicek,et al.  [The streaming liver]. , 1991, Harefuah.

[14]  R. Burk,et al.  Permanent engraftment and function of hepatocytes delivered to the liver: Implications for gene therapy and Liver Repopulation , 1991, Hepatology.

[15]  O. Terpstra.  [Auxiliary heterotopic liver transplantation]. , 1988, Nederlands tijdschrift voor geneeskunde.

[16]  B. Fuller.  Transplantation of isolated hepatocytes. A review of current ideas. , 1988, Journal of hepatology.

[17]  D. Sutherland,et al.  Prospects for hepatocyte transplantation , 1988, Hepatology.

[18]  P. Stetson,et al.  Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bromodeoxyuridine infusion in dogs. , 1987, Cancer research.

[19]  G. Kootstra,et al.  HEPATOCYTE TRANSPLANTATION FOR ENZYME DEFICIENCY DISEASE IN CONGENIC RATS , 1986, Transplantation.

[20]  O. Briggs,et al.  The fate of administered purines in the Dalmatian coach hound. , 1986, Journal of comparative pathology.

[21]  W. Buurman,et al.  Treatment of enzyme deficiency by hepatocyte transplantation in rats. , 1985, The Journal of surgical research.

[22]  O. Briggs,et al.  Serum urate concentrations in the Dalmatian Coach Hound. , 1985, Journal of comparative pathology.

[23]  T. Starzl,et al.  Liver regeneration in dogs: morphologic and chemical changes. , 1978, The Journal of surgical research.

[24]  B. Sundberg,et al.  Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. , 1977, Transplantation proceedings.

[25]  A. Matas,et al.  Transplantation of liver cells in an animal model of congenital enzyme deficiency disease: the Gunn rat. , 1977, Transplantation proceedings.

[26]  G. Kuster,et al.  Uric acid metabolism in dalmatians and other dogs. Role of the liver. , 1972, Archives of internal medicine.

[27]  C. Keeler,et al.  THE INHERITANCE OF “HIGH URIC ACID EXCRETION” IN DOGS , 1938 .